Q3 2024 Holdings
Filed 2024-11-08 | 6 holdings | $63.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $23.4M | 498,558 | 36.8% |
| Contineum Therapeutics, Inc.(CTNM) | Common Stock | 21217B100 | $17.6M | 918,163 | 27.6% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $9.1M | 2,646,657 | 14.3% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $7.9M | 2,007,704 | 12.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $3.6M | 506,821 | 5.6% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $2.1M | 3,561,150 | 3.2% |